Methylphenidate bioavailability from two extended-release formulations

International Journal of Clinical Pharmacology and Therapeutics

Volumn 40, Issue 4, 2002, Pages 175-184

  Gonzalez M A ^a   Pentikis, H S ^a   Anderl, N ^a   Benedict, M F ^a   DeCory, H H ^a   Dirksen, S J H ^a   Hatch, S J ^a  

^a Celltech Americas Inc   (United States)

Author keywords

ADHD; Bioavailability; Concerta ; Metadate CD; Methylphenidate

Indexed keywords

METHYLPHENIDATE; OROS; UNCLASSIFIED DRUG;

ADULT; ANEMIA; ANOREXIA; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG COATING; DRUG EXPOSURE; DRUG FORMULATION; DRUG RELEASE; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; MICTURITION DISORDER; NAUSEA; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TABLET FORMULATION;

EID: 0036215535     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP40175     Document Type: Article

References (20)

1. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systematic, placebo-controlled evaluation
2. Methylphenidate hydrochloride given with or before breakfast: II. Effects on plasma concentration of methylphenidate and ritalinic acid
3. Treatment of attention deficit hyperactivity disorder
4. Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder
5. Clinical studies of methylphenidate serum levels in children and adults
6. Clinical correlates of methylphenidate blood levels
7. Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HC1 in healthy subjects
8. Dose-proportional and stereospecific pharmacokinetics of methylphenidate delivered using an osmotic, controlled-release oral delivery system
9. National Institutes of Health consensus development conference statement: Diagnosis and treatment of attention deficit/hyperactivity disorder (ADHD)
10. Principles of therapeutics
11. Synthesis and pharmacology of hydroxylated metabolites of methylphenidate
12. Pharmacokinetics and actions of methylphenidate
13. Sustained-release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder
14. Relative efficacy of long-acting stimulants on children with attention deficit hyperactivity disorder: A comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline
15. Methylphenidate bioavailability in adults following an extended-release multiparticulate formulation administered sprinkled or as an intact capsule
16. Psychopharmacology of attention deficit disorder: Pharmacokinetic, neuroendocrine, and behavioral measures following acute and chronic treatment with methylphenidate
17. Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity
18. Pharmacokinetics of methylphenidate in man, rat, and monkey